NCT05935514 (VITAL-CGM) is a NA clinical trial of WW Intervention in Diabetes Mellitus, sponsored by Pennington Biomedical Research Center.

Who is sponsoring NCT05935514?

NCT05935514 is sponsored by Pennington Biomedical Research Center.

What drugs are being tested in NCT05935514?

Interventions in NCT05935514: WW Intervention, Usual Care.

What condition does NCT05935514 study?

NCT05935514 studies Diabetes Mellitus, Type 2 Diabetes, Obesity.

Is NCT05935514 still recruiting?

NCT05935514 is currently completed. Last updated 4 February 2026.

Last reviewed 2026-02-04 · How we verify

NCT05935514: VITAL-CGM

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Improving Glycemic Control Using a Virtual Weight Control Program and Continuous Glucose Monitoring

Completed NA Last updated 4 February 2026

What this trial tests

NA trial testing WW Intervention in Diabetes Mellitus in 152 participants. Completed in 23 October 2025.

Timeline

22 August 2023

Primary endpoint
23 October 2025

23 October 2025

Quick facts

Lead sponsor	Pennington Biomedical Research Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	152
Start date	22 August 2023
Primary completion	23 October 2025
Estimated completion	23 October 2025
Sites	3 locations across United States

Drugs / interventions tested

WW Intervention
Usual Care

Conditions studied

Diabetes Mellitus — all drugs for Diabetes Mellitus →
Type 2 Diabetes — all drugs for Type 2 Diabetes →
Obesity — all drugs for Obesity →

Sponsor

Pennington Biomedical Research Center — full company profile →

Who can join

Adults 18 to 69, any sex, with Diabetes Mellitus or Type 2 Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a randomized clinical trial with the primary aim examining the efficacy of a novel integrated solution of a digitally delivered behavioral weight management program tailored for diabetes utilizing a continuous glucose monitor (CGM) built into the WW digital platform for adults with type 2 diabetes (T2D) for the reduction of HbA1c.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Virtual Weight Management and Continuous Glucose Monitoring in Patients With Type 2 Diabetes: A Randomized Controlled Trial.
Katzmarzyk PT, Drews K, Ard JD, McLaughlin TL, et al · · 2026 · PMID 42047631 · DOI 10.1002/oby.70204

Verify or expand the search:

Other trials of WW Intervention

Trials testing the same drug.

NCT05663554 — Improving Glycemic Control Using a Virtual Weight Control Program Among Adults With Type 2 Diabetes · NA · withdrawn

Other recruiting trials for Diabetes Mellitus

Currently open trials in the same condition.

NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
NCT07392437 — Prevalence of Diabetes-related Distress Among Patients Living With Type 2 Diabetes in a University Hospital Center and I · NA · recruiting
NCT07448805 — Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit · NA · recruiting
NCT07425275 — Integrated Oral Care Intervention for Xerostomia in Diabetes Patients · NA · recruiting
NCT06918977 — Improving Glycemic Control With Telemedicine and Smart Insulin Pens · NA · recruiting

Other Pennington Biomedical Research Center trials

Trials by the same sponsor.

NCT07530718 — Body Composition Outcomes in MS Patients · not yet recruiting
NCT07095972 — Continuous Glucose Monitoring in Metabolic Surgery · NA · not yet recruiting
NCT07139821 — Dietary Iron Requirements · recruiting
NCT07318064 — Ultra-processed Food Consumption and Health Pilot Study · NA · not yet recruiting
NCT07305753 — CanCan Body Composition Study · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05935514 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Pennington Biomedical Research Center
Last refreshed: 4 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05935514.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing